Researchers from the University of California San Diego Herbert Wertheim School of Public Health and Human Longevity Science ...

At AACR 2026, researchers discussed the promise and challenges of bringing AI-powered tools into cancer research and clinical ...

Multimodal model delivers personalized risk estimates and clinician-adjustable insights to support surgical decisions.

Investigators sought to determine if there is a link between wildfire smoke, which is known to contain numerous carcinogens, ...

For doctors, this means constantly balancing between what is visible and what might be missed. Even subtle differences in a scan can determine whether cancer is detected early or overlooked entirely.

Lung cancer remains the leading cause of cancer-related deaths worldwide, accounting for nearly one in five cancer deaths—around 1.8 million lives lost each year. One of the main reasons is late ...

COPENHAGEN, Denmark — Screening individuals for lung cancer with low-dose CT without preselection based on their risk profile is associated with a substantial reduction in lung cancer-specific ...

Abstract: The Lung cancer remains to abundant as a leading reason of cancer-associated death worldwide, which necessitates early recognition for increasing survival rates. Standard diagnostic ...

(PUEBLO, Colo.) — UCHealth Parkview Medical Center said a new robotic biopsy system could detect lung cancer earlier in patients. UCHealth said early detection plays a critical role in improving lung ...

Clinical Trial Patient Matching: A Real-Time, Common Data Model and Artificial Intelligence–Driven System for Semiautomated Patient Prescreening in Cancer Clinical Trials We developed an eXtreme ...

LMH Health, 325 Maine St., is pictured in May 2021. “The biopsy came back positive. It’s lung cancer.” Countless people in our community hear these words no one ever expects. Lung cancer is one of the ...

bioAffinity Technologies (NASDAQ:BIAF) announced on March 10, 2026, the launch of a large longitudinal clinical study involving 2,000 patients to evaluate the performance of its CyPath® Lung ...